573
Views
30
CrossRef citations to date
0
Altmetric
Research Article

ABCA1: regulation, trafficking and association with heteromeric proteins

&
Pages 334-347 | Published online: 08 Jul 2009

References

  • Orso E, Broccardo C, Kaminski WE, Boettcher A, Liebisch G, Drobnik W, et al. Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abcl-deficient mice. Nat Genet 2000; 24: 192–6.
  • Van Helvoort A, Smith AJ, Sprong H, Fritzsche I, Schinkel AH, Borst P, et al. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 1996; 87: 507–17.
  • Klucken J, Buchler C, Orso E, Porsch Ozcurumez M, Liebisch G, Kapinski M, et al. ABCG1 (ABC8), the human homolog of the Drosophila white gene, is a regulator of macrophage cholesterol and phospholipid transport. Proc Nat! Acad Sci USA 2000; 97: 817–22.
  • Blorkhem I, Diczfalusy U, Lutjohann D. Removal of cholesterol from extrahepatic sources by oxidative mechan-isms. Curr Opin Lipidol 1999; 10: 161–5.
  • Papassotiropoulos A, Lutjohann D, Bagli M, LocateIli S, jessen F, Buschfort R, et al. 24S-hydroxycholesterol in cerebrospinal fluid is elevated in early stages of dementia. J Psychiatr Res 2002; 36: 27–32.
  • Liscum L, Klansek B. Niemann-Pick disease type C. Curr Opin Lipidol 1998; 9: 131–5.
  • Schmitz G, Robenek H, Beuck M, Krause R, Schurek A, Niemann R. ca++ antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms. I. Characterization of cellular lipid metabolism. Arteriosclero-sis 1988; 8: 46–56.
  • Langmann T, Klucken J, Reil M, Liebisch G, Luciani MF, Chimini G, et al. Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem Biophys Res Commun 1999; 257: 29–33.
  • Costet P, Luo Y, Wang N, Tall AR. sterol-dependent transactivation of the ABC1 promoter by the liver X receptor/retinoid X receptor. J Biol Chem 2000; 275: 28240–5.
  • Langmann T, Porsch-Ozcurumez M, Heimerl S, Probst M, Moehle C, Taher M, et al. Identification of sterol-indepen-dent regulatory elements in the human atp-binding cassette transporter Al (ABCA1) promoter: role of Sp1/3, E-Box binding factors and an oncostatin M responsive element. J Biol Chem 2002; 277: 14443–50.
  • Porsch-Ozcurumez M, Langmann T, Heirnerl S, Borsukova H, Kaminski WE, Drobnik W, et al. The zinc finger protein 202 (ZNF202) is a transcriptional repressor of ATP binding cassette transporter Al (ABCA1) and ABCG1 gene expression and a modulator of cellular lipid efflux. J Biol Chem 2001; 276: 12427–33.
  • Wagner S, Hess MA, Ormonde-Hanson P, Malandro J, Hu H, Chen M, et al. A broad role for the zinc finger protein ZNF202 in human lipid metabolism. J Biol Chem 2000; 275: 15685–90.
  • Lawn R111, Wade DP, Garvin MR, Wang X, Schwartz K, Porter JG, et al. The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway [see comments]. J Clin Invest 1999; 104: R25–31.
  • Lin G, Bornfeldt KE. Cyclic AMP-specific phosphodiesterase 4 inhibitors promote ABCA1 expression and cholesterol efflux. Biochem Biophys Res Commun 2002; 290: 663–9.
  • Szakacs G, Langmann T, Ozvegy C, Orso E, Schmitz G, Varadi A, et al. Characterization of the ATPase Cycle of Human ABCA1: Implications for Its Function as a Regulator Rather Than an Active Transporter. Biochem Biophys Res Commun 2001; 288: 1258–64.
  • Fu X, Menke JG, Chen Y, Zhou G, MacNaul KL, Wright SD, et al. 27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J Biol Chem 2001; 276: 38378–87.
  • Rett K. The relation between insulin resistance and cardio-vascular complications of the insulin resistance syndrome. Diabetes Obes Metab 1999; 1 Suppl 1: S8–16.
  • Schaefer E J. Familial lipoprotein disorders and premature coronary artery disease. Med Clin North Am 1994; 78: 21–39.
  • Wang Y, °tam JF. Unsaturated fatty acids inhibit cholesterol efflux from macrophages by increasing degradation of ATP-binding cassette transporter Al. J Biol Chem. 2002; 277: 5692–7.
  • Bkakdi S. [An alternative hypothesis of the pathogenesis of atherosclerosis]. Herz 1998; 23: 163–7.
  • Hla T. Sphingosine 1-phosphate receptors. Prostaglandins 2001; 64: 135–42.
  • Yatomi y, ozaki y, okmori T, Igarashi Y. Sphingosine 1- phosphate: synthesis and release. Prostaglandins 2001; 64: 107–22.
  • Levade T, Auge N, Veldman RJ, Cuvillier O, Negre- Salvayr e A, Salvayre R. Sphingolipid mediators in cardiovas- cular cell biology and pathology. Circ Res 2001; 89: 957–68.
  • Drobnilc W, Liebisch G, Schmitz G. Sphingolipid derived signaling molecules are potent regulators of apo Al induced phospholipid and cholesterol efflux. 2002 (submitted).
  • Haidar B, Mott S, Boucher B, Lee CY, Marcil M, Genest J, Jr. Cellular cholesterol efflux is modulated by phospholipid-derived signaling molecules in familial HDL deficiency/ Tangier disease fibroblasts. J Lipid Res 2001; 42: 249–57.
  • Stuns MJ, Canessa CM, Olsen JC, Hamrick M, Cohn JA, Rossier BC, et al. CFTR as a cAMP-dependent regulator of sodium channels. Science 1995; 269: 847–50.
  • Ji HL, Jovov B, Fu J, Bishop LR, Mebane HC, Fuller CM, et al.Up-regulation of acid-gated Na + channels (ASICs) by CFTR co-expression in Xenopus oocytes. J Biol Chem. 2002; 277: 8395–405.
  • Gabriel SE, Clarke LL, Boucher RC, Stutts MJ. CFTR and outward rectifying chloride channels are distinct proteins with a regulatory relationship. Nature 1993; 363: 263–8.
  • McNicholas CM, Guggino WB, Schwiebert EM, Hebert SC, Giebisch G, Egan ME. Sensitivity of a renal K+ channel (ROMK2) to the inhibitory sulfonylurea compound gliben-clamide is enhanced by coexpression with the ATP-binding cassette transporter cystic fibrosis transmembrane regulator. Proc Nat! Acad Sci USA 1996; 93: 8083–8.
  • Kaminski WE, Piehler A, Pullmann K, Porsch-Ozcurumez M, Duong C, Bared GM, et al. Complete coding sequence, promoter region, and genomic structure of the human ABCA2 gene and evidence for sterol-dependent regulation in macro-phages. Biochem Biophys Res Commun 2001; 281: 249–58.
  • Naren AP, Nelson DJ, Xie W, Jovov B, Pevsner J, Bennett MK, et al. Regulation of CFTR chloride channels by syntaxin and Munc18 isoforms. Nature 1997; 390: 302–5.
  • Sutton RB, Fasshauer D, Jahn R, Brunger AT. crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution. Nature 1998; 395: 347–53.
  • Bodzioch M, Lapidca-Bodzioch K, Buechler C, Maa Bared S, Quoc Duong C, Langmann T, et al. NIPSNAP3 and NIPSNAP4, two novel putative components of the t-SNARE complex, may participate in the vesicular processing of ABCA1 based on the results of gene expression analysis in patients with a molecular defect of ABCA1. 2002 (submitted).
  • Wang S, Yue H, Derin RB, Guggino WB, Li M. Accessory protein facilitated CFTR-CFTR interaction, a molecular mechanism to potentiate the chloride channel activity. Cell 2000; 103: 169–79.
  • Short DB, Trotter KW, Reczek D, Kreda SM, Bretscher A, Boucher RC, et al. An apical PDZ protein anchors the cystic fibrosis transmembrane conductance regulator to the cyto-skeleton. J Biol Chem 1998; 273: 19797–801.
  • Cheng J, Moyer BD, Milewski M, Lofting J, Ikeda M, Mickle JE, et al. A Golgi associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression. J Biol Chem 2002; 277: 3520–9.
  • Raghuram V, Mak DD, Foskett JK. Regulation of cystic fibrosis transmembrane conductance regulator single-channel gating by bivalent PDZ-domain-mediated interaction. Proc Nat! Acad Sci USA 2001; 98: 1300–5.
  • Songyang Z, Fanning AS, Fu C, Xu J, Marfatia SM, Chishti AH, et at. Recognition of unique carboxyl-terminal motifs by distinct PDZ domains. Science 1997; 275: 73–7.
  • Buechler C, Boettcher A, Maa Bared S, Probst MCO and Schmitz G. The carboxyterminus of the ATP Binding Cassette Transporter Al interacts with a 132-syntrophin/utrophin complex. Biochem Biophys Res Comm 2002; 293: 759–65.
  • Kachinsky AM, Froehner SC, Milgram SL. A PDZ-contain-ing scaffold related to the dystrophin complex at the basolateral membrane of epithelial cells. J Cell Biol 1999; 145: 391–402.
  • Lumeng C, Phelps S, Crawford GE, Walden PD, Barald K, Chamberlain JS. Interactions between beta 2-syntrophin and a family of microtubule-associated serine/threonine kinases. Nat Neurosci 1999; 2: 611–7.
  • Ort T, Voronov S, Guo J, et al. Dephosphorylation of beta2-syntrophin and Ca2+/mu-calpain-mediated cleavage of ICA512 upon stimulation of insulin secretion. EMBO J 2001; 20: 4013–23.
  • Shaw G. The pleckstrin homology domain: an intriguing multifunctional protein module. Bioessays 1996; 18: 35–46.
  • Lemmon MA, Ferguson KM. Signal-dependent membrane targeting by pleckstrin homology (PH) domains. Biochem J 2000; 350: 1–18.
  • Bryan J, Aguilar-Bryan L. Sulfonylurea receptors: ABC transporters that regulate ATP-sensitive K(+) channels. Biochim Biophys Acta 1999; 1461: 285–303.
  • Sharma N, Crane A, Clement JP, Gonzalez G, Babenko AP, Bryan J, et al. The C terminus of SUR1 is required for trafficking of KATP channels. J Biol Chem 1999; 274: 20628–32.
  • Reverter D, Sorimachi H, Bode W. The structure of calcium-free human m-calpain: implications for calcium activation and function. Trends Cardiovasc Med 2001; 11: 222–9.
  • Sreenan SK, Zhou YP, Otani K, Hansen PA, Currie KP, Pan CY, et al. Calpains play a role in insulin secretion and action. Diabetes 2001; 50: 2013–20.
  • Arakawa R, Yokoyama S. Helical apolipoproteins stabilize ATP-binding cassette transporter Al by protecting it from Thiol protease-mediated degradation. J Biol Chem 2002; 277: 22426–9.
  • Tsukamoto K, Hirano K, Tsujii K, Ikegami C, Zhongyan Z, Nishida Y, et at ATP-binding cassette transporter-1 induces rearrangement of actin cytoskeletons possibly through Cdc42/ N-WASP. Biochem Biophys Res Commun 2001; 287: 757–65.
  • Diederich W, Orso E, Drobnik W, Schmitz G. Apolipopro-tein AT and HDL(3) inhibit spreading of primary human monocytes through a mechanism that involves cholesterol depletion and regulation of CDC42. Atherosclerosis 2001; 159: 313–24.
  • Takai Y, Sasaki T, Matozaki T. Small GTP-binding proteins. Physiol Rev 2001; 81: 153–208.
  • McCallum SJ, Erickson JW, Cerione RA. Characterization of the association of the actin-binding protein, IQGAP, and activated Cdc42 with Golgi membranes. J Biol Chem 1998; 273: 22537–44.
  • Hirano K, Matsuura F, Tsukamoto K, Zhang Z, Matsuya-ma A, Takaishi K, et al. Decreased expression of a member of the Rho GTPase family, Cdc42Hs, in cells from Tangier disease - the small G protein may play a role in cholesterol efflux. FEBS Lett 2000; 484: 275–9.
  • Utech M, Hobbel G, Rust S, Reinecke H, Assmann G, Walter M. Accumulation of RboA, RhoB, RhoG, and Racl in fibroblasts from Tangier disease subjects suggests a regulatory role of Rho family proteins in cholesterol efflux. Biochem Biophys Res Commun 2001; 280: 229–36.
  • Simons K, Toomre D. Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 2000; 1: 31–9.
  • Mendez AJ, Lin G, Wade DP, Lawn RM, Oram JF. Membrane lipid domains distinct from cholesterol/sphingo-myelin-rich rafts are involved in the ABCA1-mediated lipid secretory pathway. J Biol Chem 2001; 276: 3158–66.
  • Drobnik W, Borsukova H, Bottcher A, Pfeiffer A, Liebisch G, Schutz GJ, et al. Apo AI/ABCA1-Dependent and HDL3- Mediated Lipid Efflux from Compositionally Distinct Choles-terol-Based Microdomains. Traffic 2002; 3: 268–78.
  • Roper K, Corbeil D, Huttner WB. Retention of prominin in microvilli reveals distinct cholesterol-based lipid micro-domains in the apical plasma membrane. Nat Cell Biol 2000; 2: 582–92.
  • Neufeld EB, Remaley AT, Demosky SJ, Stonik JA, Cooney AM, Comly M, et al. Cellular localization and trafficking of the human ABCA1 transporter. J Biol Chem 2001; 276: 27584––90.
  • Singaraj a RR, Bocher V, James ER, Clee SM, Zhang LH, Leavitt BR et al. Human ABCA1 BAC transgenic mice show increased high density lipoprotein cholesterol and ApoAI-dependent efflux stimulated by an internal promoter contain-ing liver X receptor response elements in intron 1. J Biol Chem 2001; 276: 33969–79.
  • Toyoda Y, Tsuchida A, Iwami E, Shironoguchi H, Miwa I. Regulation of hepatic glucose metabolism by translocation of glucokinase between the nucleus and the cytoplasm in hepatocytes. Horm Metab Res 2001; 33: 329–36.
  • Mendez AJ, Anantharamaiah GM, Segrest JP, Oram JF. Synthetic amphipathic helical peptides that mimic apolipo-protein A-I in clearing cellular cholesterol. J Clin Invest 1994; 94: 1698–705.
  • Remaley AT, Stonik JA, Demosky SJ, Neufeld EB, Bochar- ov AV, Vishnyakova TG, et al. Apolipoprotein specificity for lipid efflux by the human ABCAI transporter. Biochem Biophys Res Commun 2001; 280: 818–23.
  • Rees D, Sloane T, Jessup W, Dean RT, Kritharides L. Apolipoprotein A-I stimulates secretion of apolipoprotein E by foam cell macrophages. J Biol Chem 1999; 274: 27925–33.
  • Buechler C, Ritter M, Duong CQ, Orso E, Kapinsky M, Schmitz G. Adipophilin is a sensitive marker for lipid loading in human blood monocytes. Biochim Biophys Acta 2001; 1532: 97–104.
  • Van Eck M, Bos IS, Kaminski WE, Orso E, Rothe G, Twisk J et at Leukocyte ABCA1 controls susceptibility to athero-sclerosis and macrophage recruitment into tissues. Proc Natl Acad Sci USA 2002; 99: 6298–303.
  • Huang ZH, Lin CY, Oram JF, Mazzone T. Sterol efflux mediated by endogenous macrophage ApoE expression is independent of ABCA1. Arterioscler Thromb Vasc Biol 2001; 21: 2019–25.
  • Joyce CW, Amar MJ, Lambert G, Vaisman BL, Paigen B, Najib-Fruchart J, et al. The ATP binding cassette transporter Al (ABCA1) modulates the development of aortic athero-sclerosis in C57BL/6 and apoE-knockout mice. Proc Natl Acad Sci USA 2002; 99: 407–12.
  • Stohr J, Schindler G, Rothe G, Schmitz G. Enhanced upregulation of the Fc gamma receptor Ma (CD16a) during in vitro differentiation of ApoE4/4 monocytes. Arteriosder Thromb Vasc Biol 1998; 18: 1424–32.
  • Cullen P, Cignarella A, Brennhausen B, Mohr S, Assmann G, Von Eckardstein A. Phenotype-dependent differences in apolipoprotein E metabolism and in cholesterol homeostasis in human monocyte-derived macrophages. J Clin Invest 1998; 101: 1670–7.
  • Barlage S, Frohlich D, Boucher A, Jauhiainen M, Muller HP, Noetzel F, et at ApoE-containing high density lipopro- teins and phospholipid transfer protein activity increase in patients with a systemic inflammatory response. J Lipid Res 2001; 42: 281–90.
  • Wurfel MM, Wright SD. Lipopolysaccharide (LPS) binding protein catalyzes binding of LPS to lipoproteins. Prog Clin Biol Res 1995; 392: 287–95.
  • Hubacek JA, Budder C, Aslanidis C, Schmitz G. The genomic organization of the genes for human lipopolysac-charide binding protein (LBP) and bactericidial permeability increasing protein (BPI) is highly conserved. Biochem Biophys Res Comm 1997; 236: 427–30.
  • Pfeiffer A, Bottcher A, Orso E, Kapinsky M, Nagy P, Bodnar A, et al. Lipopolysaccharide and ceramide docking to CD14 provokes ligand- specific receptor clustering in rafts. Eur J Immunol. 2001; 31: 3153–64.
  • Schlegel RA, Krahling S, Callahan MK, Williamson P. CD 14 is a component of multiple recognition systems used by macrophages to phagocytose apoptotic lymphocytes. Cell Death Differ 1999; 6: 583–92.
  • Hamon Y, Broccardo C, Chambenoit 0, Luciani MF, Toti F, Chaslin S, et al. ABC1 promotes engulfment of apoptotic cells and transbilayer redistribution of phosphatidylserine. Nat Cell Biol 2000; 2: 399–406.
  • Denke MA. Connections between obesity and dyslipidaemia. Curr Opin Lipidol 2001; 12: 625–8.
  • Jenne DE, Lowin B, Peitsch MC, Bottcher A, Schmitz G, Tschopp J. Clusterin (complement lysis inhibitor) forms a high density lipoprotein complex with apolipoprotein A-I in human plasma. J Biol Chem 1991; 266: 11030–6.
  • Bajaj MS, Birktoft JJ, Steer SA, Bajaj SP. Structure and biology of tissue factor pathway inhibitor. Thromb Haemost 2001; 86: 959–72.
  • Kokawa T, Abumiya T, Kimura T, Harada-Shiba M, Koh H, Tsushima M, et al. Tissue factor pathway inhibitor activity in human plasma. Measurement of lipoprotein- associated and free forms in hyperlipidemia. Arterioscler Thromb Vasc Biol 1995; 15: 504–10.
  • Chambenoit O, Hamon Y, Marguet D, Rigneault H, Rosseneu M, Chimini G. Specific docking of apolipoprotein A-I at the cell surface requires a functional ABCA1 transpor- ter. J Biol Chem 2001; 276: 9955–60.
  • Joo F, Chevy F, Colard 0, Wolf C. The activation of rat platelets increases the exposure of polyunsaturated fatty acid enriched phospholipids on the external leaflet of the plasma membrane. Biochim Biophys Acta 1993; 1149: 231–40.
  • Shastri KM, Carvalho AC, Lees RS. Platelet function and platelet lipid composition in the dyslipoproteinemias. J Lipid Res 1980; 21: 467–72.
  • Vergani CG, Plancher AC, Zmin M, Cattaneo M, Tramaloni C, Maccari S, et al. Bile lipid composition and haemostatic variables in a case of high density lipoprotein deficiency (Tangier disease). Eur J Clin Invest 1984; 14: 49–54.
  • Wang N, Silver DL, Costet P, Tall AR. Specific binding of ApoA-I, enhanced cholesterol efflux, and altered plasma membrane morphology in cells expressing ABC1. J Biol Chem 2000; 275: 33053–8.
  • Hochgraf E, Levy Y, Aviram M, Brook JG, Cogan U. Lovastatin decreases plasma and platelet cholesterol levels and normalizes elevated platelet fluidity and aggregation in hypercholesterolemic patients. Metabolism 1994; 43: 11–7.
  • Bucki R, Janney PA, Vegners R, Giraud F, Sulpice JC. Involvement of phosphatidylinositol 4, 5-bisphosphate in phosphatidylserine exposure in platelets: use of a permeant phosphoinositide-binding peptide. Biochemistry 2001; 40: 15752–61.
  • Zha X, Genest J Jr, McPherson R. Endocytosis is enhanced in Tangier fibroblasts: possible role of ATP-binding cassette protein Al in endosomal vesicular transport. J Biol Chem 2001; 276: 39476–83.
  • Rauch C, Farge E. Endocytosis switch controlled by transmembrane osmotic pressure and phospholipid number asymmetry. Biophys J 2000; 78: 3036–47.
  • Kielar D, Langmann T, Kaminski WE, Piehler A, Wenzel J, Liebisch G, et al. ATP-binding cassette (ABC) proteins transport epidermal lipids during human keratinocyte differ- entiation: Implications for ABCA7 as a ceramide transporter. 2002 (submitted).
  • Schmitz G and Kaminski WE. ATP-binding Cassette (ABC) transporters in atherosclerosis. Curr Atheroscler Rep 2002; 4: 243–51.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.